Category: Health reform
Federal Rule Gives Regulators Enhanced Tools to Ensure Equitable Access to Behavioral Health Care

Last fall, the Biden Administration finalized a rule updating standards for the Mental Health Parity and Addiction Equity Act (MHPAEA). In their latest piece for the Commonwealth Fund, CHIR’s JoAnn Volk and Billy Dering discuss the new requirements for use of “non-quantitative treatment limits” that impose significant barriers to behavioral health treatment.
A blast from the past: Dusting off ACA Section 1333 compacts
Here’s Something to Celebrate: The Affordable Care Act Just Turned 15!
The Corporate Transformation of Health Care: Takeaways from the CHIR Webinar Series
February Research Roundup: What We’re Reading
Bringing Balance to the Market: A Roadmap for Improving Health Insurance Affordability Through Rate Review

High and rising healthcare costs in the U.S. are driven largely by escalating hospital prices, fueled by increasing consolidation among health systems. In a recent Issue Brief for the Milbank Memorial Fund, Sabrina Corlette and Karen Davenport discuss what states can do to enhance premium rate review programs, to ultimately curb provider price increases.
Bipartisan Reports Indicate It’s Time to Take Action Against Private Equity in Health Care

Private equity is not new to the health care sector, but recent growth in private equity investment has sparked a plethora of research studies, media attention, and political attention. A recent Congressional investigation and agency report, on top of continuing research indicate the time for policymakers to take action against private equity in health care is now.
January Research Roundup: What We’re Reading
Implementing the No Surprises Act: Updated Complaint Data

The No Surprises Act (NSA) has largely succeeded in protecting consumers from surprise medical bills by reducing out-of-network billing and establishing a dispute resolution process. However, while compliance has improved, challenges with the IDR process, legal actions, and incomplete data hinder a full assessment of its cost containment goals and effectiveness. CHIR experts Nadia Stovicek and Jack Hoadley discuss recent complaint data in their newest piece for CHIRblog.